The latest price target for UnitedHealth Group (NYSE:UNH) was reported by Barclays on January 17, 2025. The analyst firm set a price target for $642.00 expecting UNH to rise to within 12 months (a possible 22.58% upside). 57 analyst firms have reported ratings in the last year.

The latest analyst rating for UnitedHealth Group (NYSE:UNH) was provided by Barclays, and UnitedHealth Group maintained their overweight rating.

The last upgrade for UnitedHealth Group Inc happened on July 17, 2024 when Jefferies raised their price target to $647. Jefferies previously had a hold for UnitedHealth Group Inc.

The last downgrade for UnitedHealth Group Inc happened on March 13, 2024 when Erste Group changed their price target from N/A to N/A for UnitedHealth Group Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of UnitedHealth Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for UnitedHealth Group was filed on January 17, 2025 so you should expect the next rating to be made available sometime around January 17, 2026.

While ratings are subjective and will change, the latest UnitedHealth Group (UNH) rating was a maintained with a price target of $655.00 to $642.00. The current price UnitedHealth Group (UNH) is trading at is $523.72, which is out of the analyst’s predicted range.